BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2910189)

  • 1. Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report.
    Tucker HM
    Ann Otol Rhinol Laryngol; 1989 Jan; 98(1 Pt 1):52-4. PubMed ID: 2910189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of adductor spasmodic dysphonia with selective laryngeal adductor denervation and reinnervation surgery.
    Chhetri DK; Berke GS
    Otolaryngol Clin North Am; 2006 Feb; 39(1):101-9. PubMed ID: 16469658
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
    Genack SH; Woo P; Colton RH; Goyette D
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; MÃ¥rtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.
    Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A
    Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
    Ludlow CL; Naunton RF; Bassich CJ
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY; Lai CC; Wu PY; Huang HH
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional reinnervation of vocal folds after selective laryngeal adductor denervation-reinnervation surgery for spasmodic dysphonia.
    DeConde AS; Long JL; Armin BB; Berke GS
    J Voice; 2012 Sep; 26(5):602-3. PubMed ID: 22516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia.
    Berke GS; Blackwell KE; Gerratt BR; Verneil A; Jackson KS; Sercarz JA
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):227-31. PubMed ID: 10086613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adductor spasmodic dysphonia versus muscle tension dysphonia: examining the diagnostic value of recurrent laryngeal nerve lidocaine block.
    Roy N; Smith ME; Allen B; Merrill RM
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):161-8. PubMed ID: 17419518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent layngeal nerve section for spasmodic dysphonia.
    Levine HL; Wood BG; Batza E; Rusnov M; Tucker HM
    Ann Otol Rhinol Laryngol; 1979; 88(4 Pt 1):527-30. PubMed ID: 475250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transoral approach to laser thyroarytenoid myoneurectomy for treatment of adductor spasmodic dysphonia: short-term results.
    Su CY; Chuang HC; Tsai SS; Chiu JF
    Ann Otol Rhinol Laryngol; 2007 Jan; 116(1):11-8. PubMed ID: 17305272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine.
    Sercarz JA; Berke GS; Ming Y; Rothschiller J; Graves MC
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):657-68. PubMed ID: 1437204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective section of the recurrent laryngeal nerve for the treatment of spastic dysphonia: an experimental study and preliminary clinical report.
    Carpenter RJ; Snyder GG; Henley-Cohn JL
    Otolaryngol Head Neck Surg; 1981; 89(6):986-91. PubMed ID: 6801603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A probe into the relationship between spasmodic dysphonia and laryngeal paralysis].
    Yang S; He P; Lu S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Dec; 33(6):328-30. PubMed ID: 11938840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems with surgical (RLN section) treatment of spastic dysphonia.
    Dedo HH; Izdebski K
    Laryngoscope; 1983 Mar; 93(3):268-71. PubMed ID: 6834947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
    Koufman JA; Rees CJ; Halum SL; Blalock D
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.